Tumour cell characteristics and microenvironment composition correspond to clinical presentation in newly diagnosed nodular lymphocyte‐predominant Hodgkin lymphoma
暂无分享,去创建一个
A. Rosenwald | W. Klapper | G. Ott | A. Feller | H. Bernd | P. Möller | P. Borchmann | A. Engert | S. Hartmann | D. Eichenauer | K. Bankov | H. Stein | M. Hansmann | J. Bein | Ahmad Sajad Soltani | P. Möller | Katrin Bankov
[1] M. Piel,et al. T‐cell‐derived Hodgkin lymphoma has motility characteristics intermediate between Hodgkin and anaplastic large cell lymphoma , 2022, Journal of cellular and molecular medicine.
[2] S. Hartmann,et al. 3D analyses reveal T cells with activated nuclear features in T-cell/histiocyte-rich large B-cell lymphoma , 2022, Modern Pathology.
[3] A. Rosenwald,et al. Histopathological growth patterns in patients with advanced nodular lymphocyte‐predominant Hodgkin lymphoma treated within the randomized HD18 study: a report from the German Hodgkin Study Group , 2021, British journal of haematology.
[4] C. Kobe,et al. PET-2-guided escalated BEACOPP for advanced nodular lymphocyte-predominant Hodgkin lymphoma: a subgroup analysis of the randomized German Hodgkin Study Group HD18 study. , 2021, Annals of oncology : official journal of the European Society for Medical Oncology.
[5] A. van den Berg,et al. Soluble PD‐L1 is a promising disease biomarker but does not reflect tissue expression in classic Hodgkin lymphoma , 2021, British journal of haematology.
[6] A. Rosenwald,et al. PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial. , 2021, The Lancet. Oncology.
[7] A. LaCasce,et al. Spatial Signatures Identify Immune Escape via PD-1 as a Defining Feature of T-cell/Histiocyte-rich Large B-cell Lymphoma. , 2020, Blood.
[8] M. Hansmann,et al. Lymphocyte predominant cells of nodular lymphocyte predominant Hodgkin lymphoma interact with rosetting T cells in an immunological synapse , 2020, American journal of hematology.
[9] M. Pfreundschuh,et al. Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphoma , 2020, Nature Communications.
[10] A. Rosenwald,et al. The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma , 2019, American journal of hematology.
[11] A. Rosenwald,et al. Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] V. Beneš,et al. JUNB, DUSP2, SGK1, SOCS1 and CREBBP are frequently mutated in T-cell/histiocyte-rich large B-cell lymphoma , 2018, Haematologica.
[13] N. Johnson,et al. Distinct 3D Structural Patterns of Lamin A/C Expression in Hodgkin and Reed-Sternberg Cells , 2018, Cancers.
[14] R. Greil,et al. PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group , 2017, The Lancet.
[15] A. Engert,et al. Nodular lymphocyte-predominant Hodgkin lymphoma: a unique disease deserving unique management. , 2017, Hematology. American Society of Hematology. Education Program.
[16] Neena Kalia,et al. Biomechanical properties of human T cells in the process of activation based on diametric compression by micromanipulation. , 2017, Medical engineering & physics.
[17] Peter Bankhead,et al. QuPath: Open source software for digital pathology image analysis , 2017, Scientific Reports.
[18] A. van den Berg,et al. Characterization of the Microenvironment of Nodular Lymphocyte Predominant Hodgkin Lymphoma , 2016, International journal of molecular sciences.
[19] V. Beneš,et al. Highly recurrent mutations of SGK1, DUSP2 and JUNB in nodular lymphocyte predominant Hodgkin lymphoma , 2016, Leukemia.
[20] A. Shankar,et al. Childhood and Adolescent nodular lymphocyte predominant Hodgkin lymphoma ‐ A review of clinical outcome based on the histological variants , 2015, British journal of haematology.
[21] R. Gascoyne,et al. Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma , 2015, British journal of haematology.
[22] A. Rosenwald,et al. Histopathological features and their prognostic impact in nodular lymphocyte‐predominant Hodgkin lymphoma – a matched pair analysis from the German Hodgkin Study Group (GHSG) , 2014, British journal of haematology.
[23] G. Slack,et al. EBV May Be Expressed in the LP Cells of Nodular Lymphocyte–predominant Hodgkin Lymphoma (NLPHL) in Both Children and Adults , 2014, The American journal of surgical pathology.
[24] A. Rosenwald,et al. The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG). , 2013, Blood.
[25] R. Gascoyne,et al. Nodular Lymphocyte Predominant Hodgkin Lymphoma and T Cell/Histiocyte Rich Large B Cell Lymphoma - Endpoints of a Spectrum of One Disease? , 2013, PloS one.
[26] G. Shivashankar,et al. Model of T-cell nuclear deformation by the cortical actin layer. , 2013, Biophysical journal.
[27] C. Wolf‐peeters,et al. T cell/histiocyte-rich large B-cell lymphoma: an update on its biology and classification , 2011, Virchows Archiv.
[28] E. Morii,et al. Prognostic implication of types of tumor-associated macrophages in Hodgkin lymphoma , 2011, Virchows Archiv.
[29] P. Kamper,et al. Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin’s lymphoma , 2011, Haematologica.
[30] A. Tzankov,et al. Refined Prognostic Role of CD68-Positive Tumor Macrophages in the Context of the Cellular Micromilieu of Classical Hodgkin Lymphoma , 2011, Pathobiology.
[31] R. Warnke,et al. Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: comparison with CD57 and lymphomas in the differential diagnosis. , 2010, Human pathology.
[32] J. Delabie,et al. T-cell/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune response , 2010, Haematologica.
[33] V. Diehl,et al. Nodular lymphocyte-predominant Hodgkin lymphoma , 2008, Current hematologic malignancy reports.
[34] F. Preffer,et al. Beyond the lymphocyte predominant cell: CD4+CD8+ T-cells in nodular lymphocyte predominant Hodgkin lymphoma , 2008, Leukemia & lymphoma.
[35] E. Jaffe,et al. IgD Positive L&H Cells Identify a Unique Subset of Nodular Lymphocyte Predominant Hodgkin Lymphoma , 2006, The American journal of surgical pathology.
[36] G. Krohne,et al. The lamin CxxM motif promotes nuclear membrane growth , 2004, Journal of Cell Science.
[37] Robert Tibshirani,et al. Characterization of Variant Patterns of Nodular Lymphocyte Predominant Hodgkin Lymphoma with Immunohistologic and Clinical Correlation , 2003, The American journal of surgical pathology.
[38] V. Diehl,et al. European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. , 2000, Blood.